Subscribe to RSS - ResMed

ResMed

ResMed expands software portfolio

 - 
11/06/2018

SAN DIEGO – ResMed has signed a definitive agreement to acquire privately held MatrixCare, a provider of long-term, post-acute care software, for $750 million.

ResMed becomes platinum sponsor

 - 
11/01/2018

SAN DIEGO – ResMed has stepped up its support of AAHomecare, moving from a gold-level to a platinum level corporate partner—the highest sponsorship level for the association.

ResMed: Watch for Mobi POC early next year

Company officials also comment on growth for CPAP devices, ‘blip’ in growth for Brightree
 - 
10/26/2018

SAN DIEGO – ResMed is still keeping its plans for the Mobi portable oxygen concentrator largely under wraps.

ResMed sees 12% increase in revenue

 - 
10/26/2018

SAN DIEGO – ResMed reported revenue of $588.3 million for the first quarter of fiscal year 2019, a 12% increase over the same period in 2018. It reported a net income of $105.7 million vs. $86.1 million, a 23% increase.

ResMed wins in German court

 - 
10/23/2018

SAN DIEGO – A trial court ruling from the Munich District Court says the headgear used on two CPAP masks from Fisher & Paykel Healthcare—the Simplus full-face and Eson nasal—infringes a ResMed patent in Germany.

OSA affects more Europeans than previously thought, ResMed says

 - 
09/19/2018

PARIS – Approximately 175 million Europeans have obstructive sleep apnea, including 90 million with moderate to severe OSA, according to an abstract presented by ResMed at the European Respiratory Society’s annual ERS Congress.

F&P responds to ResMed

 - 
09/13/2018

IRVINE, Calif. – Fisher & Paykel Healthcare has filed a complaint with the U.S. International Trade Commission seeking an exclusion order to prevent the import and sale of ResMed’s AirFit P10 range of nasal pillows masks in the United States.

Growth in the sleep market continues

 - 
09/12/2018

BOSTON – Sleep center patient volume grew 7% in the last 12 months and is expected to grow 9% in the next 12 months, according to the results of a new survey conducted by Needham & Co.

In brief: Group wants liquid oxygen out, ASAA pushes for progress in sleep apnea treatment

 - 
09/07/2018

WASHINGTON – A coalition of 20 patient and physician groups is asking CMS to remove liquid oxygen from its competitive bidding program.

ResMed renews patent battle with F&P

 - 
09/04/2018

SAN DIEGO – ResMed has filed a new petition with the U.S. International Trade Commission to stop the alleged infringement of its patented technology by New Zealand-based Fisher & Paykel Healthcare. ResMed seeks an order banning the importation and sale in the U.S.

Pages